
The next generation of biotech entrepreneurs
An interdisciplinary, industry-informed degree pathway.
Life science and business professionals are in increased demand, as demonstrated by the rapidly growing bioscience hubs in Arizona and accelerated technological innovation in California.
In order to address this critical need, the McKenna Life Sciences, Business and Entrepreneurship (MLSBE) Program at Arizona State University defies traditional disciplinary boundaries to prepare academically outstanding students to solve pressing challenges in medicine and biotechnology.

Prepare to change the world.
The MLSBE Program was developed through a partnership between The College of Liberal Arts and Sciences and the W. P. Carey School of Business at ASU.
That means you have access to highly ranked and innovative courses and programs, world-class research and a robust network of experts from both schools, housed within the largest and most innovative public university in the U.S.

Industry exposure,
including events with business leaders and trips to biotech hubs across the U.S.
Top 20 ranked
finance undergraduate program.
Real-world experience
through a senior capstone project at the intersection of business and life sciences.
NeoBio and NeoChem,
new approaches to learning science with Dreamscape Learn, an immersive virtual reality experience.
Defy traditional degree boundaries.
From driving research breakthroughs to bringing new treatments to market, life science and business professionals are needed now more than ever. The MLSBE Program has been carefully crafted to build successful entrepreneurs and leaders at the intersection of science and business.
Program cohorts receive unprecedented access to industry leaders, mentorship, networking opportunities, hands-on research experience, career advising and other specialized support, all while completing two degrees and a certificate.

Getting into health care is one of the most noble professions, where you can really do well by doing good."
Mark McKenna
MLSBE Program founder
Biotech entrepreneur, executive and director
Stay tuned for application details for the first program cohort for fall 2026.